Global Burden, Rising Trends, and Future Projections of Metabolic Risks‐Related Pancreatic Cancer, With Subgroup Analysis of High Body Mass Index

ABSTRACT Background Pancreatic cancer (PC) is a global health challenge with increasing incidence and mortality. Metabolic risks, especially high body mass index (BMI), are implicated in PC development, but their impact requires a recent data assessment. This study aimed to assess the global burden and trends of PC attributable to metabolic risks from 1990 to 2021 and project future patterns to 2050. Methods We analyzed Global Burden of Disease 2021 data to assess the effects of metabolic risk on PC using deaths, disability‐adjusted life years (DALYs), years lived with disability, and years of life lost, along with their age‐standardized rates. Trends were evaluated with estimated annual percentage change and projected using autoregressive integrated moving average and exponential smoothing models. Results During 1990–2021, the global PC burden owing to metabolic risks rose significantly, with deaths and DALYs showing marked upward trends. In 2021, 138,517 PC deaths occurred globally (95% uncertainty interval [UI]: 14,518–263,207), with 2,897,229 DALYs (95% UI: 302,694–5,532,210). The estimated annual percentage change for deaths and DALYs was 2.16 (95% confidence interval [CI]: 1.85–2.47) and 1.99 (95% CI: 1.74–2.24), respectively. High‐sociodemographic index (SDI) regions had the greatest burden; low‐middle‐SDI regions showed the fastest increases. The burden related to high BMI rose, with the highest in high‐SDI regions. Men had a greater burden, except for high BMI where women were more affected. Individuals aged ≥ 70 years had the greatest burden. Forecasts predict continued PC growth through 2050, with a narrowing sex gap in mortality. Conclusion The global PC burden owing to metabolic risks, especially high BMI, continues to increase. Targeted prevention strategies to manage obesity and metabolic health are crucial to mitigate future impacts, particularly in women and low‐middle‐SDI regions.

Authors

Institutions

Publication Details

Journal
Medicine Advances
Published
2025-12-01
DOI
https://doi.org/10.1002/med4.70041
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Global Burden, Rising Trends, and Future Projections of Metabolic Risks‐Related Pancreatic Cancer, With Subgroup Analysis of High Body Mass Index

Pu Xi, Ran Wei, Lingmin Jiang, Zehui Yao et al.
Medicine Advances
Pancreatic and Hepatic Oncology Research
article

Global Burden, Rising Trends, and Future Projections of Metabolic Risks‐Related Pancreatic Cancer, With Subgroup Analysis of High Body Mass Index

Pu Xi, Ran Wei, Lingmin Jiang, Zehui Yao, Dailei Qin, Gelun Huang, Huihui Zhang, Jianzhong Cao, Qi Zhu, Shengping Li
article en

Abstract

ABSTRACT Background Pancreatic cancer (PC) is a global health challenge with increasing incidence and mortality. Metabolic risks, especially high body mass index (BMI), are implicated in PC development, but their impact requires a recent data assessment. This study aimed to assess the global burden and trends of PC attributable to metabolic risks from 1990 to 2021 and project future patterns to 2050. Methods We analyzed Global Burden of Disease 2021 data to assess the effects of metabolic risk on PC using deaths, disability‐adjusted life years (DALYs), years lived with disability, and years of life lost, along with their age‐standardized rates. Trends were evaluated with estimated annual percentage change and projected using autoregressive integrated moving average and exponential smoothing models. Results During 1990–2021, the global PC burden owing to metabolic risks rose significantly, with deaths and DALYs showing marked upward trends. In 2021, 138,517 PC deaths occurred globally (95% uncertainty interval [UI]: 14,518–263,207), with 2,897,229 DALYs (95% UI: 302,694–5,532,210). The estimated annual percentage change for deaths and DALYs was 2.16 (95% confidence interval [CI]: 1.85–2.47) and 1.99 (95% CI: 1.74–2.24), respectively. High‐sociodemographic index (SDI) regions had the greatest burden; low‐middle‐SDI regions showed the fastest increases. The burden related to high BMI rose, with the highest in high‐SDI regions. Men had a greater burden, except for high BMI where women were more affected. Individuals aged ≥ 70 years had the greatest burden. Forecasts predict continued PC growth through 2050, with a narrowing sex gap in mortality. Conclusion The global PC burden owing to metabolic risks, especially high BMI, continues to increase. Targeted prevention strategies to manage obesity and metabolic health are crucial to mitigate future impacts, particularly in women and low‐middle‐SDI regions.

Medicine AdvancesVol. 3(4)
Sun Yat-sen University (CN), National Institute of Allergy and Infectious Diseases (US), Sun Yat-sen University Cancer Center (CN)
Institute for Health Metrics and Evaluation, National Natural Science Foundation of China
Openalex Percentile: Top 31%
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.